Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q1 Loss
Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q1 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
